Advertisement

Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px
Organisation › Details

Wellington Partners Venture Capital GmbH

Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totalling more than €1.2 billion, thereof €590 million committed to life sciences, Wellington Partners has been actively supporting world class private companies translating true innovation into successful businesses with exceptional growth. To date, Wellington Partners has invested in 56 innovative life science companies, including Actelion (acquired by J&J), Definiens (acquired by AZ), immatics (Nasdaq: IMTX). invendo (acquired by Ambu), MTM Laboratories (acquired by Roche/Ventana), Oxford Immunotec (acquired by PerkinElmer), Rigontec (acquired by MSD), Symetis (acquired by Boston Scientific), and Themis (acquired by MSD). *

 

Period Start 1998-01-01 established
  Group Wellington Partners (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Strohmenger, Rainer (Wellington Partners Venture Capital 201303 General Partner)
  Person 2 Hodits, Regina (Wellington Partners 201101– General Partner before part-time advisor before Atlas Venture until 201001)
     
Region Region München (Munich)
  Country Germany
  Street 5 Türkenstr.
  City 80333 München
  Tel +49-89-219941-0
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 1,200,000,000 (fund size (2022) 2022-09-15)
     
    * Document for �About Section�: Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin.
     
   
Record changed: 2022-10-10

Advertisement

Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x200px

More documents for Wellington Partners (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2023 San Francisco 650x300px




» top